We wish the very best to you and yours in 2020! At STEM CELLS Translational Medicine (SCTM), we look forward to continuing our mission of publishing trailblazing research that will move the field closer to broader and more widespread use of stem cell therapies. But first, we want to look back and congratulate the outstanding research teams that submitted the most-read articles for 2019.
ence, as well as an article on model criteria for the regulation of cord blood banks and cord blood banking. 1 Focusing first on clinical findings, two research teams reported on the potential application of mesenchymal stromal/stem cells (MSCs) for knee arthritis, a growing concern with the aging population. Chahal et al, 2 in the #1 most-read paper, established that a single intra-articular injection of bone marrow-derived MSCs improved pain and symptoms and reduced inflammation. And Lee et al, 3 described how the intra-articular injection of autologous adipose-derived MSCs fostered functional improvements and pain relief without any apparent adverse effects.
In the second most-read paper, Campbell et al 4 In his review article, Cesario V. Borlongan 19 suggests that failed clinical trials in stroke patients may be due to a loss in translation of optimal laboratory stem cell transplantation protocols to clinical trial designs and suggests that a concerted effort between basic scientists and clinicianswith NIH and FDA guidance-is key to successful translation. Please join me in congratulating these research teams for their outstanding work. We are grateful for these and other fine research submissions, as well as to our loyal readers, a combination that has helped SCTM attain a leadership role in the field.
We are also thankful to founding editor Martin Murphy, executive editor Ann Murphy, and their dedicated staff for their vision in launching SCTM and for the work they do daily to bring these high-quality publications to our readers. A special thanks to our senior associate editor Paolo De Coppi; associate editors Geoffrey Gurtner, Douglas Losordo, Alan Trounson, and Rocky Tuan; and our distinguished editorial board members who work to ensure that the best papers can be accepted.
